Cargando…

Efficacy and tolerability of exclusive enteral nutrition in adult patients with complicated Crohn’s disease

BACKGROUND/AIMS: Exclusive enteral nutrition (EEN), an established modality for pediatric Crohn’s disease (CD) is seldomly utilized in adults. The present study reports the outcome of EEN in adult CD patients at a tertiary care hospital in India. METHODS: This was a retrospective analysis of CD pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharma, Sanchit, Gupta, Arti, Kedia, Saurabh, Agarwal, Samagra, Singh, Namrata, Goyal, Sandeep, Jain, Saransh, Gupta, Vipin, Sahu, Pabitra, Vuyyuru, Sudheer Kumar, Kante, Bhaskar, Sharma, Raju, Panwar, Rajesh, Sahni, Peush, Makharia, Govind, Ahuja, Vineet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association for the Study of Intestinal Diseases 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322023/ https://www.ncbi.nlm.nih.gov/pubmed/32447877 http://dx.doi.org/10.5217/ir.2019.09172

Ejemplares similares

Long‐term outcomes of anti‐tumor necrosis factor therapy and surgery in nonperianal fistulizing Crohn's disease
por: Vuyyuru, Sudheer K, et al.
Publicado: (2021)

Real world analysis on the efficacy and safety of anti-tumor necrosis factor therapy in patients with stricturing Crohn’s disease
por: Vuyyuru, Sudheer K., et al.
Publicado: (2021)

Efficacy and tolerability of hyperbaric oxygen therapy in small bowel stricturing Crohn’s disease: a pilot study
por: Kante, Bhaskar, et al.
Publicado: (2022)

Addition of computed tomography chest increases the diagnosis rate in patients with suspected intestinal tuberculosis
por: Kedia, Saurabh, et al.
Publicado: (2022)

High mucosal cytomegalovirus DNA helps predict adverse short-term outcome in acute severe ulcerative colitis
por: Jain, Saransh, et al.
Publicado: (2021)

Long-term Gastrointestinal Sequelae Following COVID-19: A Prospective Follow-up Cohort Study
por: Golla, Rithvik, et al.
Publicado: (2023)

Correlation of fecal calprotectin and patient-reported outcome measures in patients with ulcerative colitis
por: Kamat, Nagesh, et al.
Publicado: (2022)

Development and Validation of a Smartphone Application for Telenutrition in Patients with Inflammatory Bowel Disease
por: Gupta, Arti, et al.
Publicado: (2022)

Serum albumin is the strongest predictor of anti-tumor necrosis factor nonresponse in inflammatory bowel disease in resource-constrained regions lacking therapeutic drug monitoring
por: Kumar, Peeyush, et al.
Publicado: (2023)

Immune‐mediated inflammatory diseases of the gastrointestinal tract: Beyond Crohn's disease and ulcerative colitis
por: Vuyyuru, Sudheer K, et al.
Publicado: (2022)

High seroprevalence against SARS-CoV-2 in non-vaccinated patients with inflammatory bowel disease from Northern India
por: Kante, Bhaskar, et al.
Publicado: (2023)

Su1075: SIMILAR RISK OF INFECTION WITH SARS-COV-2 IN IMMUNOCOMPROMISED AND IMMUNOCOMPETENT PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND HEALTHY CONTROLS
por: Kante, Bhaskar, et al.
Publicado: (2022)

Differentiating Crohn’s disease from intestinal tuberculosis
por: Kedia, Saurabh, et al.
Publicado: (2019)

Left‐sided colitis and extensive colitis have similar colectomy rates after index episode of acute severe colitis: A long‐term follow‐up study
por: Jain, Saransh, et al.
Publicado: (2017)

Interferon-gamma release assay has poor diagnostic accuracy in differentiating intestinal tuberculosis from Crohn’s disease in tuberculosis endemic areas
por: Sachdeva, Karan, et al.
Publicado: (2023)

Familial aggregation of inflammatory bowel disease in patients with ulcerative colitis
por: Gupta, Akshita, et al.
Publicado: (2017)

Are Truelove and Witts criteria for diagnosing acute severe colitis relevant for the Indian population? A prospective study
por: Jain, Saransh, et al.
Publicado: (2018)

High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India
por: Agarwal, Ashish, et al.
Publicado: (2018)

Body Composition in Crohn's Disease and Ulcerative Colitis: Correlation with Disease Severity and Duration
por: Yadav, Dawesh P., et al.
Publicado: (2017)

Impact of dietary beliefs and practices on patients with inflammatory bowel disease: An observational study from India
por: Tomar, Sanjeevani K, et al.
Publicado: (2017)

Higher education, professional occupation, and upper socioeconomic status are associated with lower adherence to medications in patients with inflammatory bowel disease
por: Tomar, Sanjeevani K, et al.
Publicado: (2019)

Prevalence of hepatitis B, hepatitis C and human immunodeficiency viral infections in patients with inflammatory bowel disease in north India
por: Harsh, Parnita, et al.
Publicado: (2017)

Urinary potassium is a potential biomarker of disease activity in Ulcerative colitis and displays in vitro immunotolerant role
por: Goyal, Sandeep, et al.
Publicado: (2017)

Patients with celiac disease are at high risk of developing metabolic syndrome and fatty liver
por: Agarwal, Ashish, et al.
Publicado: (2021)

Accuracy of computed tomographic features in differentiating intestinal tuberculosis from Crohn's disease: a systematic review with meta-analysis
por: Kedia, Saurabh, et al.
Publicado: (2017)

Evaluation of Xpert MTB/RIF assay performance in the diagnosis of abdominal tuberculosis
por: Kumar, Suraj, et al.
Publicado: (2017)

Predictive factors for malignancy in undiagnosed isolated small bowel strictures
por: Sonika, Ujjwal, et al.
Publicado: (2017)

Liver stiffness assessment as an alternative to hepatic venous pressure gradient for predicting rebleed after acute variceal bleed: A proof‐of‐concept study
por: Agarwal, Samagra, et al.
Publicado: (2020)

Low dose oral curcumin is not effective in induction of remission in mild to moderate ulcerative colitis: Results from a randomized double blind placebo controlled trial
por: Kedia, Saurabh, et al.
Publicado: (2017)

Opportunities and challenges in the management of celiac disease in Asia
por: Agarwal, Ashish, et al.
Publicado: (2020)

Emergence of Celiac Disease and Gluten-related Disorders in Asia
por: Mohta, Srikant, et al.
Publicado: (2021)

Personalized medicine to implementation science: Thiopurines set for the leap
por: Sharma, Vishal, et al.
Publicado: (2022)

Who to screen and how to screen for celiac disease
por: Singh, Prashant, et al.
Publicado: (2022)

Genome-wide gene expression analysis for target genes to differentiate patients with intestinal tuberculosis and Crohn’s disease and discriminative value of FOXP3 mRNA expression
por: Ahuja, Vineet, et al.
Publicado: (2016)

Prospective validation of CD4(+) CD25(+) FOXP3(+) T-regulatory cells as an immunological marker to differentiate intestinal tuberculosis from Crohn’s disease
por: Rampal, Ritika, et al.
Publicado: (2021)

Randomised clinical trial: effect of adding branched chain amino acids to exercise and standard-of-care on muscle mass in cirrhotic patients with sarcopenia
por: Mohta, Srikant, et al.
Publicado: (2022)

Presence and type of decompensation affects outcomes in autoimmune hepatitis upon treatment with corticosteroids
por: Sharma, Sanchit, et al.
Publicado: (2020)

Fecal microbiota transplantation refurbishes the crypt-associated microbiota in ulcerative colitis
por: Markandey, Manasvini, et al.
Publicado: (2023)

BioFuelDB: a database and prediction server of enzymes involved in biofuels production
por: Chaudhary, Nikhil, et al.
Publicado: (2017)

CD4(+) CD25(+) FOXP3(+) T cell frequency in the peripheral blood is a biomarker that distinguishes intestinal tuberculosis from Crohn’s disease
por: Tiwari, Veena, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8e1ch1l6fosgd45pulaadpn86g